WallStreetZenWallStreetZen

NASDAQ: SKIN
Beauty Health Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SKIN

Based on 7 analysts offering 12 month price targets for Beauty Health Co.
Min Forecast
$11.00-9.17%
Avg Forecast
$20.86+72.23%
Max Forecast
$35.00+189.02%

Should I buy or sell SKIN stock?

Based on 7 analysts offering ratings for Beauty Health Co.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
1 analysts 14.29%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SKIN stock forecasts and price targets.

SKIN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Benchmark
Bottom 17%
17
Strong BuyReiterates$23.00+89.93%2023-03-14
DA Davidson
Top 18%
83
Strong BuyMaintains$35.00+189.02%2023-03-01
Cowen & Co.
Bottom 10%
10
BuyMaintains$15.00+23.86%2023-02-16
Goldman Sachs
Top 14%
87
Strong BuyMaintains$19.00+56.90%2022-11-23
JP Morgan
Top 33%
68
HoldDowngrades$11.00-9.17%2022-11-09
Piper Sandler
Top 12%
89
Strong BuyMaintains$23.00+89.93%2022-09-16
Canaccord Genuity
Top 13%
88
Strong BuyMaintains$20.00+65.15%2022-06-30
Anonymous
Goldman Sachs
Strong BuyMaintains$25.00+106.44%2022-05-11

1 of 1

Forecast return on equity

Is SKIN forecast to generate an efficient return?
Company
40.18%
Industry
47.53%
Market
52.51%
SKIN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SKIN forecast to generate an efficient return on assets?
Company
6.83%
Industry
13.2%
SKIN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SKIN earnings per share forecast

What is SKIN's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$0.19-36.67%
Avg 2 year Forecast
$0.30+0%
Avg 3 year Forecast
$0.52+73.33%
SKIN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SKIN revenue forecast

What is SKIN's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$425.2M+16.2%
Avg 2 year Forecast
$505.3M+38.12%
Avg 3 year Forecast
$594.6M+62.5%
SKIN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SKIN earnings growth forecast

How is SKIN forecast to perform vs Household & Personal Products companies and vs the US market?
Company
4.19%
Industry
9.57%
Market
26.86%
SKIN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SKIN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SKIN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SKIN revenue growth forecast

How is SKIN forecast to perform vs Household & Personal Products companies and vs the US market?
Company
17.84%
Industry
3.01%
Market
9.33%
SKIN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SKIN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SKIN vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
SKIN$12.11$20.86+72.23%Strong Buy
NUS$38.94$39.33+1.01%Hold
HIMS$9.53$11.94+25.27%Strong Buy
USNA$61.36$52.75-14.03%Sell
HELE$89.05$134.00+50.48%Strong Buy
View Top Household & Personal Product Stocks

Beauty Health Co Stock Forecast FAQ

Is Beauty Health Co Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: SKIN) stock is to Strong Buy SKIN stock.

Out of 7 analysts, 5 (71.43%) are recommending SKIN as a Strong Buy, 1 (14.29%) are recommending SKIN as a Buy, 1 (14.29%) are recommending SKIN as a Hold, 0 (0%) are recommending SKIN as a Sell, and 0 (0%) are recommending SKIN as a Strong Sell.

If you're new to stock investing, here's how to buy Beauty Health Co stock.

What is SKIN's earnings growth forecast for 2023-2025?

(NASDAQ: SKIN) Beauty Health Co's forecast annual earnings growth rate of 4.19% is not forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 9.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 26.86%.

Beauty Health Co's earnings in 2023 is $44,384,000.On average, 7 Wall Street analysts forecast SKIN's earnings for 2023 to be $25,175,009, with the lowest SKIN earnings forecast at $5,300,002, and the highest SKIN earnings forecast at $41,075,015. On average, 4 Wall Street analysts forecast SKIN's earnings for 2024 to be $39,750,015, with the lowest SKIN earnings forecast at $19,875,007, and the highest SKIN earnings forecast at $53,000,020.

In 2025, SKIN is forecast to generate $68,900,025 in earnings, with the lowest earnings forecast at $68,900,025 and the highest earnings forecast at $68,900,025.

What is SKIN's revenue growth forecast for 2023-2025?

(NASDAQ: SKIN) Beauty Health Co's forecast annual revenue growth rate of 17.84% is forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 3.01%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.33%.

Beauty Health Co's revenue in 2023 is $365,876,000.On average, 6 Wall Street analysts forecast SKIN's revenue for 2023 to be $56,334,383,333, with the lowest SKIN revenue forecast at $55,226,020,423, and the highest SKIN revenue forecast at $57,359,271,212. On average, 4 Wall Street analysts forecast SKIN's revenue for 2024 to be $66,956,912,261, with the lowest SKIN revenue forecast at $64,002,823,669, and the highest SKIN revenue forecast at $69,072,275,544.

In 2025, SKIN is forecast to generate $78,777,904,133 in revenue, with the lowest revenue forecast at $78,559,279,052 and the highest revenue forecast at $78,996,529,214.

What is SKIN's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: SKIN) forecast ROA is 6.83%, which is lower than the forecast US Household & Personal Products industry average of 13.2%.

What is SKIN's Price Target?

According to 7 Wall Street analysts that have issued a 1 year SKIN price target, the average SKIN price target is $20.86, with the highest SKIN stock price forecast at $35.00 and the lowest SKIN stock price forecast at $11.00.

On average, Wall Street analysts predict that Beauty Health Co's share price could reach $20.86 by Mar 14, 2024. The average Beauty Health Co stock price prediction forecasts a potential upside of 72.23% from the current SKIN share price of $12.11.

What is SKIN's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: SKIN) Beauty Health Co's current Earnings Per Share (EPS) is $0.30. On average, analysts forecast that SKIN's EPS will be $0.19 for 2023, with the lowest EPS forecast at $0.04, and the highest EPS forecast at $0.31. On average, analysts forecast that SKIN's EPS will be $0.30 for 2024, with the lowest EPS forecast at $0.15, and the highest EPS forecast at $0.40. In 2025, SKIN's EPS is forecast to hit $0.52 (min: $0.52, max: $0.52).

What is SKIN's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: SKIN) forecast ROE is 40.18%, which is considered strong.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.